What is Kyntra Bio, Inc.?
, a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing FG-3246, a potential antibody-drug conjugate targeting CD46, for the treatment of metastatic castration-resistant prostate cancer and other cancers. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 6.32M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.